Delphine Le Louet
Stock Analyst at Bernstein
(0.34)
# 4,293
Out of 4,574 analysts
176
Total ratings
39%
Success rate
-7.3%
Average return
Main Sectors:
Stocks Rated by Delphine Le Louet
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Buy | €284.00 | €221.00 | +28.51% | 21 | Jul 21, 2026 | |
| ETR: GXI Gerresheimer AG | Upgraded: Hold | €18.90 → €28.70 | €26.28 | +9.21% | 14 | Jul 1, 2026 | |
| AMS: LKFT Lakefront Biotherapeutics NV | Maintained: Hold | €27.90 | €24.50 | +13.88% | 2 | Mar 31, 2026 | |
| SWX: TECN Tecan Group AG | Upgraded: Hold | CHF 165.20 → CHF 156.00 | CHF 182.20 | -14.38% | 2 | Jan 16, 2026 | |
| STO: GETI.B Getinge AB (publ) | Initiated Coverage: Hold | kr 228.00 | kr 230.30 | n/a | 1 | Jun 17, 2025 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Hold | €172.00 → €234.00 | €167.30 | n/a | 14 | Apr 16, 2025 | |
| EPA: ERF Eurofins Scientific SE | Maintained: Hold | €52.80 → €53.80 | €66.40 | n/a | 7 | Nov 28, 2024 | |
| EPA: DBV DBV Technologies S.A. | Maintained: Buy | €5.70 → €3.03 | €2.38 | n/a | 10 | Mar 17, 2024 | |
| SWX: ALC Alcon Inc. | Maintained: Hold | CHF 77.60 → CHF 72.20 | CHF 55.74 | n/a | 16 | Feb 29, 2024 | |
| EPA: IPN Ipsen S.A. | Maintained: Buy | €142.00 → €150.40 | €158.40 | n/a | 14 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 → €13.60 | €3.82 | n/a | 9 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €57.00 → €57.10 | €35.06 | n/a | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €20.10 → €18.95 | €23.16 | n/a | 12 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €186.40 → €189.80 | €163.50 | n/a | 19 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €103.00 → €101.00 | €69.90 | n/a | 15 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $26.17 | n/a | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €579.00 → €612.00 | €174.00 | n/a | 6 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $13 | $13.63 | n/a | 4 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $144 | $92.54 | n/a | 1 | Oct 8, 2020 |
Sartorius Aktiengesellschaft
Jul 21, 2026
Maintained: Buy
Price Target: €284.00
Current: €221.00
Upside: +28.51%
Gerresheimer AG
Jul 1, 2026
Upgraded: Hold
Price Target: €18.90 → €28.70
Current: €26.28
Upside: +9.21%
Lakefront Biotherapeutics NV
Mar 31, 2026
Maintained: Hold
Price Target: €27.90
Current: €24.50
Upside: +13.88%
Tecan Group AG
Jan 16, 2026
Upgraded: Hold
Price Target: CHF 165.20 → CHF 156.00
Current: CHF 182.20
Upside: -14.38%
Getinge AB (publ)
Jun 17, 2025
Initiated Coverage: Hold
Price Target: kr 228.00
Current: kr 230.30
Upside: n/a
Sartorius Stedim Biotech S.A.
Apr 16, 2025
Maintained: Hold
Price Target: €172.00 → €234.00
Current: €167.30
Upside: n/a
Eurofins Scientific SE
Nov 28, 2024
Maintained: Hold
Price Target: €52.80 → €53.80
Current: €66.40
Upside: n/a
DBV Technologies S.A.
Mar 17, 2024
Maintained: Buy
Price Target: €5.70 → €3.03
Current: €2.38
Upside: n/a
Alcon Inc.
Feb 29, 2024
Maintained: Hold
Price Target: CHF 77.60 → CHF 72.20
Current: CHF 55.74
Upside: n/a
Ipsen S.A.
Jan 3, 2024
Maintained: Buy
Price Target: €142.00 → €150.40
Current: €158.40
Upside: n/a
Dec 22, 2023
Maintained: Buy
Price Target: €20.30 → €13.60
Current: €3.82
Upside: n/a
Nov 13, 2023
Maintained: Buy
Price Target: €57.00 → €57.10
Current: €35.06
Upside: n/a
Oct 24, 2023
Maintained: Hold
Price Target: €20.10 → €18.95
Current: €23.16
Upside: n/a
Oct 20, 2023
Upgraded: Buy
Price Target: €186.40 → €189.80
Current: €163.50
Upside: n/a
Sep 29, 2023
Maintained: Hold
Price Target: €103.00 → €101.00
Current: €69.90
Upside: n/a
Oct 13, 2022
Downgraded: Hold
Price Target: n/a
Current: $26.17
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: €579.00 → €612.00
Current: €174.00
Upside: n/a
May 4, 2021
Upgraded: Hold
Price Target: $13
Current: $13.63
Upside: n/a
Oct 8, 2020
Upgraded: Hold
Price Target: $144
Current: $92.54
Upside: n/a